{'fraction_non_alphanumeric': 0.022452504317789293, 'fraction_numerical': 0.0069084628670120895, 'mean_word_length': 5.304347826086956, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
HIV disease susceptibility in women and the barriers to adherence.

The late 1990s saw a decrease in the total number of new cases of HIV (human immunodeficiency virus) and AIDS (acquired immunodeficiency syndrome). However, data often do not reflect the increased incidence of HIV in women, particularly women from minority groups. The purposes of this clinical review are to address the disease susceptibility and disease manifestations of HIV in women, and to discuss selected barriers to adherence to antiretroviral medications such as stigma, social support, and depression.